非侵入性血糖监测市场（按产品类型、应用、技术、最终用户和地区）2024 年至 2031 年

非侵入性血糖仪市场评估 - 2024-2031

全球糖尿病盛行率的上升，正在增加全球对非侵入性血糖仪等微创设备的需求。因此，生活方式的改变、久坐不动的生活方式、不良饮食习惯以及遗传因素正在推动非侵入性血糖仪的销售。糖尿病盛行率的上升正推动市场规模呈指数级增长，预计到2024年将超过1.6365亿美元，到2031年将达到2.77亿美元。

预计非侵入式连续血糖监测市场将持续成长，这得益于消费者健康意识的提升以及技术先进产品的广泛应用，这些因素预计将成为主要驱动力。因此，对非侵入式连续血糖监测日益增长的偏好预计将推动该市场在2024年至2031年间以6.80%的复合年增长率成长。

非侵入式血糖仪市场定义/概述

非侵入性血糖仪是糖尿病管理技术领域的革命性工具，无需刺穿皮肤即可测量血糖值。与需要刺穿手指的传统血糖仪不同，这些设备采用光谱和无线电波等非侵入式方法来分析皮下液体和组织。这种无痛便捷的方法改善了糖尿病患者的使用体验。

这些血糖仪的主要目的是为糖尿病患者提供一种舒适易用的血糖值监测方式。便捷的操作有助于持续频繁地监测，这对于有效的糖尿病管理至关重要。这有助于及早发现血糖值波动并及时干预。非侵入式监测还可以改善血糖控制，并预防与糖尿病相关的长期併发症，例如心血管疾病、神经病变和视网膜病变。

糖尿病患者意识的提高将如何推动非侵入式血糖仪市场的成长？

随着糖尿病患者越来越意识到定期监测血糖的重要性，非侵入性血糖仪市场正在不断扩大。医疗保健计划、教育宣传活动以及全球糖尿病疫情的推动也推动了这个市场的发展。光谱法、电阻测量法和光同调断层扫瞄(OCT) 等非侵入性血糖监测设备的技术进步，正在彻底改变血糖仪的准确性、可靠性和使用者体验。这些最尖端科技使患者能够轻鬆监测血糖浓度，避免了传统侵入式方法的不适和不便。

由于传统的指尖采血操作既不舒服又不方便，人们对无痛便捷的血糖监测解决方案的需求日益增长。非侵入性血糖仪提供了一种极具吸引力的替代方案，它无需频繁进行皮肤采血，使监测过程更加舒适。这种身体不适感的减少可以鼓励糖尿病患者更规律地监测血糖，这对于有效的疾病管理和改善健康至关重要。

非侵入式血糖监测设备在家庭护理环境中的日益普及，将使患者能够在家中舒适地监测血糖值，从而更积极地管理自身健康。全球人口老化的发展也推动了非侵入式血糖仪市场的扩张，因为老龄化人群患糖尿病及其相关併发症的风险更高。

优惠的报销政策和政府推动有效糖尿病管理的倡议进一步推动了市场成长。随着全球糖尿病发病率持续上升，对便捷有效的血糖监测解决方案的需求预计将进一步推动市场扩张。

缺乏认识和怀疑态度将如何阻碍非侵入性血糖监测市场的成长？

非侵入性血糖仪市场面临许多挑战，包括糖尿病患者对这些设备的准确性和可靠性的质疑、医疗专业人员认知度的差距、监管挑战、来自替代血糖监测解决方案的日益激烈的竞争以及经济因素。传统的侵入式血糖仪方法，例如指尖采血和抽血，因其可靠性和广泛接受度而仍然广受欢迎。此外，巨大的教育差距阻碍了患者充分了解非侵入性血糖仪的潜在益处。医疗专业人员也可能因为不熟悉该技术或对其有效性存在担忧而犹豫是否支持非侵入性血糖仪技术。

严格的要求和冗长的核准流程等监管挑战可能会延迟新产品的推出，并阻碍商业化进程。对于寻求全球产品上市的製造商来说，应对不同地区不同监管环境的复杂性进一步加剧了这个过程。

此外，市场还面临着来自持续血糖监测系统和植入式血糖感测器等新兴技术的日益激烈的竞争，这些技术通常被认为更先进、更准确。这些替代技术加剧了竞争格局，使非侵入式血糖监测更难获得市场份额。

价格压力和报销限制等经济因素也限制非侵入式血糖仪市场的成长。製造商必须平衡定价策略，确保价格可负担的同时保持盈利，而这在註重成本的医疗保健系统中很难实现，因为报销限制会限制患者获得非侵入式血糖监测设备。预计这将导致单位销售额下降和市场成长放缓。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第三章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 非侵入性血糖仪市场：依技术

• 近红外线光谱（NIRS）
• 光同调断层扫瞄（OCT）
• 中红外线光谱
• 拉曼光谱
• 萤光
• 电阻光谱
• 其他的

5. 非侵入性血糖监测市场（依产品类型）

• 穿戴式无创血糖监测仪
• 非穿戴式无创血糖监测仪

6. 非侵入式血糖仪市场（依最终用户）

• 医院
• 居家医疗
• 其他的

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市占率分析

第十章：公司简介

• Abbott（US）
• PHC Holdings Corporation（Japan）
• Sanofi（France）
• Dexcom, Inc（US）
• Medtronic（Ireland）
• B. Braun SE（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• LifeScan（US）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• AgaMatrix（US）
• DarioHealth（Israel）
• Becton Dickinson and Company（US）

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Non-Invasive Glucose Meter Market Valuation - 2024-2031

The global demand for minimally invasive devices, such as non-invasive glucose meters, is increasing due to the rising prevalence of diabetes worldwide. Thus, the changing lifestyle habits, sedentary lifestyles, poor dietary choices, and genetic factors are factors likely to boost the sales of non-invasive glucose meter. 'The increasing prevalence of diabetes is surging the growth of the market size surpassing USD 163.65 Million in 2024 to reach a valuation of USD 277 Million by 2031.

The non-invasive continuous glucose monitoring market is expected to grow due to rising health consciousness among consumers and widespread adoption of technologically advanced products, which are expected to be major contributors. Thus, the increasing preference for non-invasive continuous glucose monitoring enables the market to grow at a CAGR of 6.80% from 2024 to 2031.

Non-Invasive Glucose Meter Market: Definition/ Overview

A non-invasive glucose meter is a revolutionary tool in diabetes management technology that measures blood sugar levels without skin penetration. Unlike traditional glucose meters that require finger pricking, these devices use non-invasive methods like spectroscopy and radio waves to analyze body fluids or tissues beneath the skin's surface. This painless and convenient method enhances the user experience for diabetic patients.

The primary purpose of these meters is to empower individuals with diabetes by providing a comfortable and user-friendly way to monitor their blood glucose levels. The ease of use encourages consistent and frequent monitoring, which is crucial for effective diabetes management. This leads to earlier detection of blood sugar fluctuations and timely interventions. Non-invasive monitoring can also improve glycemic control, preventing long-term complications associated with diabetes, such as cardiovascular diseases, neuropathy, and retinopathy.

How Does the Rising Awareness Among Diabetic Patients Surge the Growth of the Non-Invasive Glucose Meter Market?

The non-invasive glucose meter market is expanding due to increasing awareness among diabetic patients about the importance of regular glucose monitoring. This is driven by healthcare initiatives, educational campaigns, and the global prevalence of diabetes. Technological advancements in non-invasive glucose monitoring devices, such as spectroscopy, impedance-based measurements, and optical coherence tomography (OCT), are revolutionizing the accuracy, reliability, and user experience of glucose meters. These cutting-edge technologies make it easier for patients to monitor their glucose levels without the discomfort and inconvenience traditionally associated with invasive methods.

The demand for painless and convenient glucose monitoring solutions is on the rise, as traditional finger pricks and blood draws are uncomfortable and inconvenient. Non-invasive glucose meters offer a compelling alternative by eliminating the need for frequent skin punctures, making the monitoring process more comfortable. This reduction in physical discomfort encourages diabetic patients to engage in more regular blood sugar monitoring, essential for effective disease management and improved health outcomes.

The increasing adoption of non-invasive glucose meters in homecare settings allows patients to monitor their glucose levels in the comfort of their own homes, empowering them to take a more proactive role in managing their health. The growing global geriatric population is also driving the expansion of the non-invasive glucose meter market, as they are at a higher risk of developing diabetes and its associated complications.

Favorable reimbursement policies and government initiatives promoting effective diabetes management are further fostering market growth. As diabetes continues to rise globally, the need for convenient and effective glucose monitoring solutions is expected to further accelerate market expansion.

How will the Lack of Awareness and Skepticism Hamper the Growth of Non-Invasive Glucose Meter Market?

The non-invasive glucose meter market faces several challenges, including skepticism among diabetic patients about the accuracy and reliability of these devices, a gap in awareness among healthcare professionals, regulatory challenges, increasing competition from alternative glucose monitoring solutions, and economic factors. Traditional invasive methods like finger pricks and blood draws remain popular due to their reliability and widespread acceptance. Additionally, there is a significant educational gap that prevents patients from fully appreciating the potential benefits of non-invasive methods. Healthcare professionals may also be hesitant to endorse non-invasive meters due to unfamiliarity with the technology or concerns about their effectiveness.

Regulatory challenges, such as stringent requirements and lengthy approval processes, can delay the introduction of new products, hindering commercialization efforts. The complexity of navigating diverse regulatory landscapes across different regions further complicates the process for manufacturers seeking to launch their products globally.

Additionally, the market is facing increasing competition from emerging technologies like continuous glucose monitoring systems and implantable glucose sensors, which are often seen as more advanced or accurate. These alternatives intensify the competitive landscape, making it more challenging for non-invasive options to gain market share.

Economic factors, such as pricing pressures and reimbursement limitations, also constrain the growth of the non-invasive glucose meter market. Manufacturers must balance pricing strategies to ensure affordability while remaining profitable, but this is difficult to achieve in cost-conscious healthcare systems where reimbursement constraints can limit patient access to non-invasive glucose monitoring devices. This is projected to lead to reduced sales volumes and slower market growth.

Category-Wise Acumens

How did the Adoption of Wearable Glucose Monitoring Surge the Growth of the Wearable Devices Segment?

The wearable devices segment is dominating segment in the non-invasive glucose meter market due to advancements in healthcare and technology. These devices offer compact, discreet, and real-time data tracking, revolutionizing diabetes management by providing convenience and minimal disruption to daily life. The compact design and ease of use enable patients to integrate these devices into their routines, improving adherence to monitoring regimens.

The growing trend towards remote patient monitoring and telehealth services is another significant factor contributing to the rising demand for wearable glucose meters. Wearable glucose meters empower patients by allowing them to continuously track their glucose levels and transmit the data to healthcare professionals in real time, facilitating timely interventions, personalized treatment plans, and proactive diabetes management.

The integration of wearable glucose meters with smartphone applications and cloud-based platforms enhances data accessibility and usability. These devices can sync seamlessly with mobile apps, enabling patients to easily view and analyze their glucose data. Cloud-based platforms offer a centralized location for accessing patient data, making it easier to monitor trends, adjust treatment plans, and provide personalized care.

The increasing prevalence of diabetes globally and the demand for continuous glucose monitoring solutions are pivotal in driving the adoption of wearable devices. By offering real-time insights into glucose levels, these devices help patients maintain better glycemic control, reducing the risk of complications such as cardiovascular disease, neuropathy, and retinopathy.

How Advanced Techniques and Highly Accurate Glucose Level Measurement Foster the Growth of Spectroscopy-based Segment?

Spectroscopy-based meters are a popular choice for diabetic patients and healthcare providers due to their advanced technology, near-infrared (NIR) spectroscopy, which provides highly accurate glucose level measurements. This precision allows patients to make informed decisions about their treatment regimens and lifestyle adjustments, leading to better health outcomes.

The simplicity and ease of use of spectroscopy-based meters make them accessible to a wide range of users, including elderly individuals and those with limited mobility or dexterity. This ease of use promotes adherence to glucose monitoring regimens, essential for managing diabetes effectively.

Continuous monitoring of glucose levels provides patients with valuable insights into their blood sugar levels, enabling early detection of significant changes and timely interventions to prevent severe episodes of hyperglycemia or hypoglycemia. The real-time monitoring feature is particularly beneficial for patients who need to closely manage their glucose levels due to volatile or unpredictable patterns.

Spectroscopy-based meters are often integrated with mobile applications and cloud-based platforms, enhancing the accessibility and usability of the data generated. Patients can easily sync their glucose data to their smartphones or tablets, allowing them to track trends, set reminders, and share information with healthcare providers.

The compact and portable design of spectroscopy-based meters enhances their convenience, allowing patients to monitor their glucose levels on the go, especially for those with active lifestyles. This enables more effective and flexible diabetes management, empowering individuals to maintain control over their health regardless of their location.

Country/Region-wise Acumens

How the Increasing Adoption of Non-Invasive Glucose Meter Foster the Growth of Non-Invasive Glucose Meter Market in North America?

North America dominates the non-invasive glucose meter market due to the high prevalence of diabetes and growing awareness of the importance of regular glucose monitoring. The region's advanced healthcare infrastructure and favorable reimbursement policies support the widespread adoption of non-invasive glucose meters. Healthcare providers in North America are increasingly recognizing the benefits of these devices, which improve patient outcomes and reduce costs associated with diabetes management. Government initiatives, such as public health campaigns, educational programs, and financial incentives, contribute to a heightened focus on proactive diabetes management.

The emphasis on technological innovation and research and development in this region is also driving market growth. Leading medical device companies and research institutions are at the forefront of advancing non-invasive glucose monitoring technologies, investing heavily in the development of cutting-edge products with enhanced accuracy, reliability, and user-friendliness. The continuous introduction of these advanced devices fuels market demand and accelerates their adoption across the healthcare landscape.

The growing trend toward telehealth and remote patient monitoring services in North America is also boosting the demand for non-invasive glucose meters. These devices allow patients to conveniently monitor their glucose levels at home and share real-time data with their healthcare providers, enabling timely interventions and personalized treatment plans. Overall, North America's healthcare infrastructure and focus on innovation and research contribute to its dominance in the non-invasive glucose meter market.

How Does the Increasing Diabetic Population in Asia Pacific Foster the Growth of the Non-Invasive Glucose Meter Market?

The Asia Pacific region is expected to experience the fastest growth in the non-invasive glucose meter market due to the increasing diabetic population and growing awareness of the importance of regular glucose monitoring. Rapid economic development and urbanization are playing a crucial role in this anticipated market expansion.

As countries continue to develop economically, access to healthcare services improves and healthcare expenditure increases, making advanced medical technologies, including non-invasive glucose meters, more accessible to a broader segment of the population. The growing acceptance and adoption of these devices among healthcare providers and patients further fuels market growth.

Government initiatives aimed at addressing the growing burden of diabetes are another key factor driving the non-invasive glucose meter market in the Asia Pacific. Governments are implementing public health campaigns, educational programs, and subsidized healthcare services to raise awareness about diabetes management and the importance of regular glucose monitoring.

Favorable regulatory policies and reimbursement schemes in many countries facilitate market access for manufacturers, promoting the adoption of non-invasive glucose meters among healthcare providers and patients. The increasing trend towards digital health and telemedicine in the Asia Pacific is further accelerating the demand for innovative healthcare solutions, including non-invasive glucose meters.

Competitive Landscape

The Non-Invasive Glucose Meter Market is a rapidly evolving field with numerous players vying for market share. While traditional invasive methods have dominated the market for decades, advancements in technology have led to increased interest in non-invasive alternatives. This competitive landscape is characterized by a mix of established medical device companies, innovative startups, and research institutions.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the non-invasive glucose meter market include:

• Abbott
• PHC Holdings Corporation
• Sanofi
• Dexcom, Inc.
• Medtronic
• Braun SE
• Hoffmann-La Roche Ltd.
• LifeScan
• Ascensia Diabetes Care Holdings AG
• AgaMatrix
• DarioHealth
• Becton Dickinson & Company

Latest Developments:

• In February 2024, Dexcom, Inc. announced the launch of Dexcom ONE+, the latest Continuous Glucose Monitoring (CGM), to bring strong, new diabetes care technologies to patients in Belgium, Spain, and Poland.
• In January 2024, Abbott and Tandem Diabetes Care, Inc., a player in insulin delivery and diabetes technologies, unveiled the t: slim X2 insulin pump with Control-IQ technology making it the first automated insulin administration system in the United States to combine with the
• FreeStyle Libre 2 Plus sensor. This enabled the organization to strengthen its product portfolio.
• In January 2024, Medtronic got CE approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one Continuous Glucose Monitor (CGM) that does not require fingersticks or overtape, intending to strengthen its product line.
• In September 2023, Nemaura Medical announced the completion of a clinical trial with 100 patients using the sugar beet, a non-invasive and flexible continuous glucose monitor. The study was carried out in the Middle East and included four groups, each with an equal number of male and female volunteers aged 18 to 75 years. Twenty of the patients had type 1 diabetes, with the others having type 2 diabetes.

Non-Invasive Glucose Meter Market, By Category

• Product Type:
• Wearable Devices
• Standalone Devices
• Accessories & Consumables
• Application:
• Diabetes Management
• Continuous Glucose Monitoring
• Research & Development
• Technology:
• Spectroscopy-Based
• Impedance-Based
• Optical Coherence Tomography
• Thermal-Based
• End-User:
• Hospitals & Clinics
• Homecare Settings
• Diagnostic Laboratories
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Non-Invasive Glucose Meter Market, By Technology

• Near Infrared Spectroscopy (NIRS)
• Optical Coherence Tomography (OCT)
• Mid-Infrared Spectroscopy
• Raman Spectroscopy
• Fluorescence
• Impedance Spectroscopy
• Others

5. Non-Invasive Glucose Meter Market, By Product Type

• Wearable Non-Invasive Glucose Monitors
• Non-Wearable Non-Invasive Glucose Monitors

6. Non-Invasive Glucose Meter Market, By End-User

• Hospitals
• Homecare Settings
• Others

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott (U.S.)
• PHC Holdings Corporation (Japan)
• Sanofi (France)
• Dexcom, Inc (U.S.)
• Medtronic (Ireland)
• B. Braun SE (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)
• LifeScan (U.S.)
• Ascensia Diabetes Care Holdings AG (Switzerland)
• AgaMatrix (U.S.)
• DarioHealth (Israel)
• Becton Dickinson and Company (U.S.)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References